Enlisting Deep Learning in the War on Cancer

By John Russell

December 7, 2016

Sometime in Q2 2017 the first ‘results’ of the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) will become publicly available according to Rick Stevens. He leads one of three JDACS4C pilot projects pressing deep learning (DL) into service in the War on Cancer. The pilots, supported in part by DOE exascale funding, not only seek to do good by advancing cancer research and therapy but also to advance deep learning capabilities and infrastructure with an eye towards eventual use on exascale machines.

By any standard, the U.S. War on Cancer and the Precision Medicine Initiative’s (PMI) are ambitious. Past Wars on Cancer haven’t necessarily fared well, which is not to say much hasn’t been accomplished. Today’s timing seems more promising. Progress in biomedical science and the ramp-up of next gen leadership computers (en route to exascale) are powerful enablers. Stir in the rapid emergence of deep learning to exploit data-driven science and many see greater cause for optimism. Not by chance was the opening plenary panel at SC16 on precision medicine and the role of HPC.

The three JDACS4C pilots span molecular to population scale efforts in support of the CANcer Distributed Learning Environment (CANDLE) project: they are intended to “provide insight into scalable machine learning tools; deep learning, simulation and analytics to reduce time to solution; and inform design of future computing solutions.” The hope is also to establish “a new paradigm for cancer research for years to come by making effective use of the ever-growing volumes and diversity of cancer-related data to build predictive models, provide better understanding of the disease and, ultimately, provide guidance and support decisions on anticipated outcomes of treatment for individual patients.”

Rick Stevens, ANL

These are ambitious goals. Sorting out JDACS4C’s precise lineage is a little challenging – it falls broadly under the Precision Medicine Initiative, NCI Cancer Moonshot, and has been also lumped under NSCI. Stevens noted the early discussion to create the effort started a couple of years ago with the first funding issued in the August time frame. Here’s a snapshot of the three pilots:

  • RAS Molecular Project. This project (Molecular Level Pilot for RAS Structure and Dynamics in Cellular Membranes) is intended to develop new computational approaches supporting research already being done under the RAS Initiative. Ultimately the hope is to refine our understanding of the role of the RAS (gene family) and its associated signaling pathway in cancer and to identify new therapeutic targets uniquely present in RAS protein membrane signaling complexes.
  • Pre-Clinical Screening. This project (Cellular Level Pilot for Predictive Modeling for Pre-clinical Screening) will develop “machine learning, large-scale data and predictive models based on experimental biological data derived from patient-derived xenografts.” The idea is to create a feedback loop, where the experimental models inform the design of the computational models. These predictive models may point to new targets in cancer and help identify new treatments.

Not surprisingly, there are many organizational pieces required. NCI components include the Center for Biomedical Informatics and Information Technology (CBIIT), the Division of Cancer Treatment and Diagnosis (DCTD), the Division of Cancer Control and Population Science (DCCPS), and the Frederick National Laboratory for Cancer Research. There are also four DOE National Laboratories formally designated on the project – Argonne National Laboratory, Oak Ridge National Laboratory, Lawrence Livermore National Laboratory, and Los Alamos National Laboratory.

As the projects came together, “We realized each had a need for deep learning and different uses of it. So the idea is that we would all work together on building both the software environment and network topologies and everything we would need for the three projects so we wouldn’t have duplication,” said Stevens. The researchers defined key benchmarks that “are tractable kinds of deep learning problems that are aligned with what we have to solve for the different cancer sub problems.”

An early first step was attracting vendor participation – something that turned out to be easy said Stevens because virtually all the major HPC vendors are aggressively ramping up DL roadmaps. Most see the JDACS4C pilots as opportunities to learn and refine. Stevens said JDASC4C has collaborations with Intel, Cray, NVIDIA, IBM, among others.

“All of the labs have DGX-1s and NVIDIA has optimized most of the common frameworks for the different GPUs, Pascal, etc. The DGX-1 is like an appliance so anything we build that runs on the DGX-1 can be easily distributed. Intel has it own extensive plans and not all is public yet. I can say that we are collaborating with all the right parts of Intel,” said Stevens, an ANL researcher and leader of the pre-clinical screening project.

Indeed Intel has been busy, buying Nervana (a complete platform for DL) and recently rolling out expanded plans. “They are talking about versions of Knights X series that are optimized for machine learning. Knights Mill is the first version of that part of their roadmap,” said Stevens. The chip giant also introduced a DL inference accelerator card at SC16; it’s a field-programmable gate array (FPGA)-based hardware and software solution for neural network acceleration. Stevens suggests Intel, like NVIDIA, is developing an appliance strategy.

“Intel is very much trying to define a strategy that differentiates some level between the platform for training and for inferencing. Most deep learning systems now do inferencing on the ‘quasi’ client side – on smaller platforms than used for training. Intel wants to ensure “future IA architectures are good at inferencing,” he said.

Not surprisingly  there’s a fair amount of effort assessing the many DL frameworks coming out of the Google, Microsoft, Facebook et al. “We are evaluating which frameworks work best for our problems and we are working with vendors to optimize them on the hardware. We’re also working with Livermore which has an internal project to build a scalable artificial neural network framework call LBANN,” said Stevens.

The plan is to develop “our models in a way that is independent of the frameworks so we can swap out the frameworks as those evolve without having to recode our models. This is a very common approach with deep learning where you have a scripting layer that captures your model representation – the meta algorithms for training and management data, etc. – and we are working with both the academic community and the NVIDIA on the workflow engine at the top. So we have kind of a stacked architecture and it involves collaborating with all of the different groups around the DL landscape.”

“What’s interesting,” said Stevens, “is the vendors for the next-gen platforms are strongly embracing the architectural ideas and features needed for accelerated machine learning in addition to traditional kind of physics-driven simulation.” He noted that market pressures and the fast growth of DL compared to the traditional HPC are pushing them in this direction. “It’s also giving us insight into DOE applications that are going to start looking like this – where there will be traditional physics-driven simulation, but where often we can find a way to leverage machine learning [too].”

Sharing the learning is an important component of the pilot projects. “We are abstracting model problems for the machine learning community to work on that are kind of sanitized versions of the seven candle benchmarks we’re working on,” said Stevens. That will include distributable data, code, all to be available at GitHub. The first of those elements are expected in Q2.

Individual pilot teams are also mounting their own outreach activities with the academic community. In terms of compute power for the pilots, “We are targeting platforms, particularly the CORAL platforms, new machines at Argonne, Oak Ridge and Livermore, and [eventually] exascale. Everything is sort of ecumenical so its not GPU specific or manycore specific.”

It’s interesting to look at the different ways in which the three projects plan to use deep learning.

The RAS project, at the molecular scale, is the smallest dimensional scale of all of the projects. RAS, you may know, is a well-known family of oncogenes that code for signaling proteins embedded in the cell membrane. These proteins control signaling pathways that extend into the cell and drive very many diverse cellular processes. RAS is currently implicated in about 30 percent of cancers including some of the toughest such as pancreatic cancer. The pilot project will combine simulation and wet lab screening data in an effort to elaborate the details of the RAS-related signaling cascades and hopefully identify key places to intervene and new drugs to use.

Even a relatively small tumor may have “thousands of mutations, both driver mutations and many passenger mutations,” said Stevens. These genetic miscues can alter the important details of signaling networks. For many years RAS itself as well as its associated signaling networks have been drug targets but as Stevens pointed out, “the behavior of that signaling network is very non-intuitive. Sometimes if you hit one of the downstream components, it actually creates negative feedback, which actually increases the effect you are trying to inhibit.”

In the RAS project, the simulation is basically a molecular dynamics exercise conducted at various granularities extending all the way down to atomistic behavior including quantum effects. The computational power required, not surprisingly, depends on the level of granularity being simulated and can be substantial.

“Machine learning is being used to track the state space that the simulation is going through and to make decisions – do we zoom in here, do we zoom out, do we change the parameters that we are looking in a different part to the ensemble space. It’s basically acting like a smart supervisor of this simulation to more effectively use it.

“In some sense it’s like the network is watching a movie and saying, “OK, I’ve seen this part of the movie before, let’s fast forward, or wow this is really interesting I’ve never seen this before, let’s use slow motion and zoom in.” That’s sort of what the machine learning is doing in the simulation. It’s able to fast forward and skip around in some sense,” said Stevens.

The pre-clinical screening project, led by Stevens, is an ambitious effort to sift through basically as much cancer  preclinical and clinical data as it can lay hold of and combine that with new data generated from mouse models to build predictive models of drug-tumor interactions. It’s an in silico and experimental feedback approach. Ultimately, given a specific tumor whose molecular attributes (gene expression, SNPs, proteomics, etc) have been characterized, it should be possible to plug that data into a model to determine the best therapeutic regime.

The subtlety here, said Stevens, is there has been a lot of machine learning work in this done at kind of the small scale, that is on single classes of tumors or relatively small classes of drugs. “What we are trying to do with the deep learning is to integrate all of this information across thousands of cell lines, tens of thousands of compounds that have been screened against smaller number of cell lines, and then be able to project that into a mouse. You grow a colony of mice derived from that human tumor, and these mice become proxies for human clinical trials. So I can try different compounds on the colony of tumor mice to provide information about how my tumor might respond to them if given as a drug.”

A huge challenge is being able to make sense of all the historical data, much of which is unstructured and often subjective (e.g. pathology reports). “One of the first things that we have done is to build classifiers to tell us what type the tumor is or where the body site is [based on diverse data],” he said. Not infrequently the data may be suspect. “If it’s a new dataset we run it through our classifiers and they may say, really, this is not from the liver, it’s from some other place.”

As a rule, the preclinical data is outcome based; it doesn’t explain how the result was achieved.

“Right now we can build machine learning models that are pretty accurate at say predicting a drug response or tumor type or outcome but they can’t tell us very effectively why. They are not explanatory, not mechanistic,” said Stevens, “What we want to do is bring in mechanistic models or mechanistic data in some way and hybridize that with machine learning models so that we get two things. We get the ability to have a highly accurate predictable model but also a model that can explain why that prediction. So the idea of this hybrid approach is a wide open space and we think that this will generalize into many fields.” Obtaining large and high quality data for training models remains challenging, he said.

The third project strives to develop models able to make population scale forecasts, what Stevens call “patient trajectories.” It’s basically mining surveillance data across the country. Although somewhat dispersed, there is a great deal of patient data held by NCI, NIH, FDA, pharma, and payor organizations (pathology reports, treatments, outcomes, lifestyle, demographics, etc.). Unfortunately, like a lot of biomedical data, it’s largely unstructured. “We can’t really compute on it in the way we want to so we are using machine learning to translate the unstructured data into structured data we can compute on,” said Stevens

“So for example we want to read all the pathology reports with a machine and pull out, say the biomarkers, the mutational state, or the drugs and so on such that we can then build profiles that are consistent. Think of it as a population-based model. In preclinical screening pilot let’s say we uncover some treatments and strategies that are very effective on a certain type of cancer. We want to take that information and feed it into the population model and say “If this became a common therapy, how much would it change the statistics globally or nationally” or something like that.”

It’s also a way to link all of the pilots, said Steven. Insight from the RAS project might be later used to look at subclasses of cancers where the new treatment might work; that in turn put it into the population model to understand what the impact of that might be.

It’s still early days for the JDACS4C pilot projects, but hopes are high. Stevens noted both NCI and DOE are getting access to things they don’t readily have. “NCI does not have a lot of mathematicians and computer scientists, which DOE has. They also don’t have access to leadership machines. What we (DOE) are getting is access to all of this great experimental data, experimental facilities, public databases.”

Subscribe to HPCwire's Weekly Update!

Be the most informed person in the room! Stay ahead of the tech trends with industy updates delivered to you every week!

Women Coders from Russia, Italy, and Poland Top Study

January 17, 2017

According to a study posted on HackerRank today the best women coders as judged by performance on HackerRank challenges come from Russia, Italy, and Poland. Read more…

By John Russell

Spurred by Global Ambitions, Inspur in Joint HPC Deal with DDN

January 17, 2017

Inspur, the fast-growth cloud computing and server vendor from China that has several systems on the current Top500 list, and DDN, a leader in high-end storage, have announced a joint sales and marketing agreement to produce solutions based on DDN storage platforms integrated with servers, networking, software and services from Inspur. Read more…

By Doug Black

Weekly Twitter Roundup (Jan. 12, 2017)

January 12, 2017

Here at HPCwire, we aim to keep the HPC community apprised of the most relevant and interesting news items that get tweeted throughout the week. Read more…

By Thomas Ayres

NSF Seeks Input on Cyberinfrastructure Advances Needed

January 12, 2017

In cased you missed it, the National Science Foundation posted a “Dear Colleague Letter” (DCL) late last week seeking input on needs for the next generation of cyberinfrastructure to support science and engineering. Read more…

By John Russell

HPE Extreme Performance Solutions

Remote Visualization: An Integral Technology for Upstream Oil & Gas

As the exploration and production (E&P) of natural resources evolves into an even more complex and vital task, visualization technology has become integral for the upstream oil and gas industry. Read more…

NSF Approves Bridges Phase 2 Upgrade for Broader Research Use

January 12, 2017

The recently completed phase 2 upgrade of the Bridges supercomputer at the Pittsburgh Supercomputing Center (PSC) has been approved by the National Science Foundation (NSF) making it now available for research allocations to the national scientific community, according to an announcement posted this week on the XSEDE web site. Read more…

By John Russell

Clemson Software Optimizes Big Data Transfers

January 11, 2017

Data-intensive science is not a new phenomenon as the high-energy physics and astrophysics communities can certainly attest, but today more and more scientists are facing steep data and throughput challenges fueled by soaring data volumes and the demands of global-scale collaboration. Read more…

By Tiffany Trader

For IBM/OpenPOWER: Success in 2017 = (Volume) Sales

January 11, 2017

To a large degree IBM and the OpenPOWER Foundation have done what they said they would – assembling a substantial and growing ecosystem and bringing Power-based products to market, all in about three years. Read more…

By John Russell

UberCloud Cites Progress in HPC Cloud Computing

January 10, 2017

200 HPC cloud experiments, 80 case studies, and a ton of hands-on experience gained, that’s the harvest of four years of UberCloud HPC Experiments. Read more…

By Wolfgang Gentzsch and Burak Yenier

Spurred by Global Ambitions, Inspur in Joint HPC Deal with DDN

January 17, 2017

Inspur, the fast-growth cloud computing and server vendor from China that has several systems on the current Top500 list, and DDN, a leader in high-end storage, have announced a joint sales and marketing agreement to produce solutions based on DDN storage platforms integrated with servers, networking, software and services from Inspur. Read more…

By Doug Black

For IBM/OpenPOWER: Success in 2017 = (Volume) Sales

January 11, 2017

To a large degree IBM and the OpenPOWER Foundation have done what they said they would – assembling a substantial and growing ecosystem and bringing Power-based products to market, all in about three years. Read more…

By John Russell

UberCloud Cites Progress in HPC Cloud Computing

January 10, 2017

200 HPC cloud experiments, 80 case studies, and a ton of hands-on experience gained, that’s the harvest of four years of UberCloud HPC Experiments. Read more…

By Wolfgang Gentzsch and Burak Yenier

A Conversation with Women in HPC Director Toni Collis

January 6, 2017

In this SC16 video interview, HPCwire Managing Editor Tiffany Trader sits down with Toni Collis, the director and founder of the Women in HPC (WHPC) network, to discuss the strides made since the organization’s debut in 2014. Read more…

By Tiffany Trader

BioTeam’s Berman Charts 2017 HPC Trends in Life Sciences

January 4, 2017

Twenty years ago high performance computing was nearly absent from life sciences. Today it’s used throughout life sciences and biomedical research. Genomics and the data deluge from modern lab instruments are the main drivers, but so is the longer-term desire to perform predictive simulation in support of Precision Medicine (PM). There’s even a specialized life sciences supercomputer, ‘Anton’ from D.E. Shaw Research, and the Pittsburgh Supercomputing Center is standing up its second Anton 2 and actively soliciting project proposals. There’s a lot going on. Read more…

By John Russell

Fast Rewind: 2016 Was a Wild Ride for HPC

December 23, 2016

Some years quietly sneak by – 2016 not so much. It’s safe to say there are always forces reshaping the HPC landscape but this year’s bunch seemed like a noisy lot. Among the noisemakers: TaihuLight, DGX-1/Pascal, Dell EMC & HPE-SGI et al., KNL to market, OPA-IB chest thumping, Fujitsu-ARM, new U.S. President-elect, BREXIT, JR’s Intel Exit, Exascale (whatever that means now), NCSA@30, whither NSCI, Deep Learning mania, HPC identity crisis…You get the picture. Read more…

By John Russell

AWI Uses New Cray Cluster for Earth Sciences and Bioinformatics

December 22, 2016

The Alfred Wegener Institute, Helmholtz Centre for Polar and Marine Research (AWI), headquartered in Bremerhaven, Germany, is one of the country's premier research institutes within the Helmholtz Association of German Research Centres, and is an internationally respected center of expertise for polar and marine research. In November 2015, AWI awarded Cray a contract to install a cluster supercomputer that would help the institute accelerate time to discovery. Now the effort is starting to pay off. Read more…

By Linda Barney

Addison Snell: The ‘Wild West’ of HPC Disaggregation

December 16, 2016

We caught up with Addison Snell, CEO of HPC industry watcher Intersect360, at SC16 last month, and Snell had his expected, extensive list of insights into trends driving advanced-scale technology in both the commercial and research sectors. Read more…

By Doug Black

AWS Beats Azure to K80 General Availability

September 30, 2016

Amazon Web Services has seeded its cloud with Nvidia Tesla K80 GPUs to meet the growing demand for accelerated computing across an increasingly-diverse range of workloads. The P2 instance family is a welcome addition for compute- and data-focused users who were growing frustrated with the performance limitations of Amazon's G2 instances, which are backed by three-year-old Nvidia GRID K520 graphics cards. Read more…

By Tiffany Trader

US, China Vie for Supercomputing Supremacy

November 14, 2016

The 48th edition of the TOP500 list is fresh off the presses and while there is no new number one system, as previously teased by China, there are a number of notable entrants from the US and around the world and significant trends to report on. Read more…

By Tiffany Trader

Vectors: How the Old Became New Again in Supercomputing

September 26, 2016

Vector instructions, once a powerful performance innovation of supercomputing in the 1970s and 1980s became an obsolete technology in the 1990s. But like the mythical phoenix bird, vector instructions have arisen from the ashes. Here is the history of a technology that went from new to old then back to new. Read more…

By Lynd Stringer

For IBM/OpenPOWER: Success in 2017 = (Volume) Sales

January 11, 2017

To a large degree IBM and the OpenPOWER Foundation have done what they said they would – assembling a substantial and growing ecosystem and bringing Power-based products to market, all in about three years. Read more…

By John Russell

Container App ‘Singularity’ Eases Scientific Computing

October 20, 2016

HPC container platform Singularity is just six months out from its 1.0 release but already is making inroads across the HPC research landscape. It's in use at Lawrence Berkeley National Laboratory (LBNL), where Singularity founder Gregory Kurtzer has worked in the High Performance Computing Services (HPCS) group for 16 years. Read more…

By Tiffany Trader

Dell EMC Engineers Strategy to Democratize HPC

September 29, 2016

The freshly minted Dell EMC division of Dell Technologies is on a mission to take HPC mainstream with a strategy that hinges on engineered solutions, beginning with a focus on three industry verticals: manufacturing, research and life sciences. "Unlike traditional HPC where everybody bought parts, assembled parts and ran the workloads and did iterative engineering, we want folks to focus on time to innovation and let us worry about the infrastructure," said Jim Ganthier, senior vice president, validated solutions organization at Dell EMC Converged Platforms Solution Division. Read more…

By Tiffany Trader

Lighting up Aurora: Behind the Scenes at the Creation of the DOE’s Upcoming 200 Petaflops Supercomputer

December 1, 2016

In April 2015, U.S. Department of Energy Undersecretary Franklin Orr announced that Intel would be the prime contractor for Aurora: Read more…

By Jan Rowell

Enlisting Deep Learning in the War on Cancer

December 7, 2016

Sometime in Q2 2017 the first ‘results’ of the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C) will become publicly available according to Rick Stevens. He leads one of three JDACS4C pilot projects pressing deep learning (DL) into service in the War on Cancer. Read more…

By John Russell

Leading Solution Providers

D-Wave SC16 Update: What’s Bo Ewald Saying These Days

November 18, 2016

Tucked in a back section of the SC16 exhibit hall, quantum computing pioneer D-Wave has been talking up its new 2000-qubit processor announced in September. Forget for a moment the criticism sometimes aimed at D-Wave. This small Canadian company has sold several machines including, for example, ones to Lockheed and NASA, and has worked with Google on mapping machine learning problems to quantum computing. In July Los Alamos National Laboratory took possession of a 1000-quibit D-Wave 2X system that LANL ordered a year ago around the time of SC15. Read more…

By John Russell

CPU Benchmarking: Haswell Versus POWER8

June 2, 2015

With OpenPOWER activity ramping up and IBM’s prominent role in the upcoming DOE machines Summit and Sierra, it’s a good time to look at how the IBM POWER CPU stacks up against the x86 Xeon Haswell CPU from Intel. Read more…

By Tiffany Trader

Nvidia Sees Bright Future for AI Supercomputing

November 23, 2016

Graphics chipmaker Nvidia made a strong showing at SC16 in Salt Lake City last week. Read more…

By Tiffany Trader

New Genomics Pipeline Combines AWS, Local HPC, and Supercomputing

September 22, 2016

Declining DNA sequencing costs and the rush to do whole genome sequencing (WGS) of large cohort populations – think 5000 subjects now, but many more thousands soon – presents a formidable computational challenge to researchers attempting to make sense of large cohort datasets. Read more…

By John Russell

Beyond von Neumann, Neuromorphic Computing Steadily Advances

March 21, 2016

Neuromorphic computing – brain inspired computing – has long been a tantalizing goal. The human brain does with around 20 watts what supercomputers do with megawatts. And power consumption isn’t the only difference. Fundamentally, brains ‘think differently’ than the von Neumann architecture-based computers. While neuromorphic computing progress has been intriguing, it has still not proven very practical. Read more…

By John Russell

The Exascale Computing Project Awards $39.8M to 22 Projects

September 7, 2016

The Department of Energy’s Exascale Computing Project (ECP) hit an important milestone today with the announcement of its first round of funding, moving the nation closer to its goal of reaching capable exascale computing by 2023. Read more…

By Tiffany Trader

Dell Knights Landing Machine Sets New STAC Records

November 2, 2016

The Securities Technology Analysis Center, commonly known as STAC, has released a new report characterizing the performance of the Knight Landing-based Dell PowerEdge C6320p server on the STAC-A2 benchmarking suite, widely used by the financial services industry to test and evaluate computing platforms. The Dell machine has set new records for both the baseline Greeks benchmark and the large Greeks benchmark. Read more…

By Tiffany Trader

What Knights Landing Is Not

June 18, 2016

As we get ready to launch the newest member of the Intel Xeon Phi family, code named Knights Landing, it is natural that there be some questions and potentially some confusion. Read more…

By James Reinders, Intel

  • arrow
  • Click Here for More Headlines
  • arrow
Share This